
Michael Shapiro is a cardiologist specializing in preventive cardiology. He is the inaugural Fred M. Parrish Professor of Cardiology and Molecular Medicine and Professor of Cardiovascular Medicine at Wake Forest University School of Medicine, where he directs the Center for Prevention of Cardiovascular Disease and co-directs the NIH T32 Fellowship Program in Cardiovascular Disease Epidemiology and Prevention. Clinically, Dr. Shapiro focuses on lipid disorders, advanced cardiovascular imaging, and primary prevention with individualized risk stratification. His research centers on lipid metabolism and atherosclerosis, advanced atherosclerosis imaging and imaging biomarkers, and clinical trials of lipid‑modifying therapies and precision risk prediction, including machine learning. He serves as President of the American Society for Preventive Cardiology and Chair-elect of the AHA Council on Lipidology, Lipoprotein, Metabolism, & Thrombosis, and has been recognized as an Elite Reviewer for the ACC Simon Dack Award for Outstanding Scholarship. Dr. Shapiro earned his DO from Rowan University School of Osteopathic Medicine, completed internal medicine residency and cardiovascular disease fellowship at the Icahn School of Medicine at Mount Sinai/Beth Israel Medical Center, and an advanced cardiovascular imaging research fellowship at Massachusetts General Hospital and Harvard Medical School.
Professor
2019 – present